Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HMGA2-mediated glutamine metabolism is required for Cd-induced cell growth and cell migration. | Toxicology | 2024 | 39032683 | PubTator, text mining | PubMed |
| Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. | Cancer Res | 2024 | 38959335 | PubTator, text mining | PubMed |
| Growth characteristics of HCT116 xenografts lacking asparagine synthetase vary according to sex. | Hum Genomics | 2024 | 38886847 | PubTator, text mining | PubMed |
| Genome-wide determinants of mortality and motor progression in Parkinson's disease. | NPJ Parkinsons Dis | 2024 | 38849413 | PubTator, text mining | PubMed |
| ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer. | Sci Rep | 2024 | 38844625 | PubTator, text mining | PubMed |
| Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. | J Proteome Res | 2024 | 38829961 | PubTator, text mining | PubMed |
| Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project. | Hum Genomics | 2024 | 38685113 | PubTator, text mining | PubMed |
| Revisiting Exome Data Identified Missed Splice Site Variant of the Asparagine Synthetase ( ASNS ) Gene. | J Pediatr Genet | 2024 | 38567172 | PubTator, text mining | PubMed |
| A novel variant in ASNS gene responsible for syndromic intellectual disability and microcephaly: Case report and literature review. | Mol Genet Genomic Med | 2024 | 38546112 | PubTator, text mining | PubMed |
| Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis. | Ir J Med Sci | 2024 | 38523167 | PubTator, text mining | PubMed |
| AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis. | Cell Death Dis | 2024 | 38521813 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer. | Int J Mol Sci | 2024 | 38474084 | PubTator, text mining | PubMed |
| Metabolism of asparagine in the physiological state and cancer. | Cell Commun Signal | 2024 | 38448969 | PubTator, text mining | PubMed |
| Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism. | Chem Sci | 2024 | 38362406 | PubTator, text mining | PubMed |
| GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. | Exp Hematol Oncol | 2024 | 38291540 | PubTator, text mining | PubMed |
| A novel diabetic foot ulcer diagnostic model: identification and analysis of genes related to glutamine metabolism and immune infiltration. | BMC Genomics | 2024 | 38287255 | PubTator, text mining | PubMed |
| Ribosome profiling: a powerful tool in oncological research. | Biomark Res | 2024 | 38273337 | PubTator, text mining | PubMed |
| Glutamine metabolism-related genes and immunotherapy in nonspecific orbital inflammation were validated using bioinformatics and machine learning. | BMC Genomics | 2024 | 38233749 | PubTator, text mining | PubMed |
| Amino acid metabolism in tumor biology and therapy. | Cell Death Dis | 2024 | 38218942 | PubTator, text mining | PubMed |
| An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer. | Aging (Albany NY) | 2024 | 38206293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=6